vimarsana.com
Home
Live Updates
UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis : comparemela.com
UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis
Utidelone injectable has received FDA orphan drug designation for patients with breast cancer brain metastases.
Related Keywords
Biostar Pharma ,
Biostar Pharma Inc ,
,
Response Assessment ,
Fda ,
Breast Cancer Brain Metastases ,
Fda Orphan Drug Designation ,
Utidelone Injectable ,
comparemela.com © 2020. All Rights Reserved.